Inhibition of FGFR2 and FGFR1 increases cisplatin sensitivity in ovarian cancer

Claire Cole, Sin Lau, Alison Backen, Andrew Clamp, Graham Rushton, Caroline Dive, Cassandra Hodgkinson, Rhona McVey, Henry Kitchener, Gordon C. Jayson

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Inhibition of FGFR2 and FGFR1 increases cisplatin sensitivity in ovarian cancer'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Medicine and Dentistry